1) pioglitazone
吡格列酮
1.
Pioglitazone Combined Insulin for Type 2 Diabetes Mellitus;
吡格列酮与胰岛素联合治疗2型糖尿病疗效观察
2.
Effects of insulin and pioglitazone on proliferation,apoptosis and NO secretion of endothelial progenitor cells;
吡格列酮和胰岛素对内皮祖细胞增殖和凋亡及分泌一氧化氮的影响
3.
Relationship between nonalcoholic fatty liver disease and levels of serum adiponectin and tumor necrosis factor-α in obese rats and pioglitazone intervention;
肥胖大鼠非酒精性脂肪肝与血清脂联素和肿瘤坏死因子α的关系及吡格列酮干预
2) Pioglitazone Hydrochloride
盐酸吡格列酮
1.
Research to manufacture the Pioglitazone Hydrochloride orally disintegrating tablets;
盐酸吡格列酮口腔崩解片的研制
2.
Determination of Pioglitazone Hydrochloride Tablets by HPLC;
盐酸吡格列酮片的HPLC含量测定方法
3) pioglitazone hydrochloride tablets
盐酸吡格列酮片
1.
Dissolution comparison of pioglitazone hydrochloride tablets from different producers by process analysis;
过程分析比较不同厂家盐酸吡格列酮片的溶出度
2.
Pharmacokinetics of pioglitazone hydrochloride tablets in healthy human subjects after a single dose administration;
单剂口服盐酸吡格列酮片在健康人体的药代动力学
3.
Studies on the dissoulution rate of pioglitazone hydrochloride tablets;
盐酸吡格列酮片的溶出度研究
4) Pioglitazone
盐酸吡格列酮
1.
Effects of pioglitazone on the insulin resistance in the muscle tissue;
盐酸吡格列酮对肌肉组织胰岛素抵抗发生的影响
2.
Study on the prevention of insulin resistance of pioglitazone in the rats induced by high-fat diet;
盐酸吡格列酮对高脂诱导大鼠胰岛素抵抗的干预作用
3.
The clinical research of Pioglitazone treating typeⅡdiabeties;
盐酸吡格列酮治疗2型糖尿病临床研究
5) metabolites M-Ⅲ
吡格列酮代谢物M-Ⅲ
6) pioglitazone /metformin
吡格列酮二甲双胍片
1.
Objective To evaluate the efficacy and safety of pioglitazone /metformin hydrochloride in the treatment of type 2 diabetes mellitus patients.
目的以盐酸二甲双胍和盐酸吡格列酮(均降糖药)为对照,评价吡格列酮二甲双胍片治疗2型糖尿病的疗效和安全性。
补充资料：吡格列酮
分子式：C19H20N2O3S
分子量：356.4386
CAS号：111025-46-8
性质：暂无
制备方法：暂无
用途：治疗(Ⅱ)型糖尿病
分子量：356.4386
CAS号：111025-46-8
性质：暂无
制备方法：暂无
用途：治疗(Ⅱ)型糖尿病
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条